Digestive System End-stage liver disease patients scheduled for liver transplantation
Conditions
Interventions
Standard platelets count
Sponsors
National liver institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: End stage liver disease scheduled for adult liver transplantation.
Exclusion criteria
Exclusion criteria: Patients on preoperative oral anticoagulant, antiplatelets. Patients on any drugs affecting platelets function and count or causing pancytopenia e.g Impenam, Diflucan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet function behaviour | — |
Secondary
| Measure | Time frame |
|---|---|
| Anti-platelet monitoring | — |
Countries
Egypt
Contacts
Public ContactElsayedamr Basma
Patient Information Manager
Outcome results
None listed